Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Invested Capital (2018 - 2025)

Volitionrx filings provide 11 years of Invested Capital readings, the most recent being -$28.9 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 16.52% to -$28.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$28.9 million, a 16.52% decrease, with the full-year FY2025 number at -$28.9 million, down 16.52% from a year prior.
  • Invested Capital hit -$28.9 million in Q4 2025 for Volitionrx, up from -$29.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $34.4 million in Q1 2021 to a low of -$29.5 million in Q3 2025.
  • Median Invested Capital over the past 5 years was -$1.3 million (2022), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Invested Capital: surged 189.97% in 2021 and later tumbled 3717.5% in 2024.
  • Volitionrx's Invested Capital stood at $17.8 million in 2021, then plummeted by 116.91% to -$3.0 million in 2022, then crashed by 186.17% to -$8.6 million in 2023, then tumbled by 188.29% to -$24.8 million in 2024, then fell by 16.52% to -$28.9 million in 2025.
  • The last three reported values for Invested Capital were -$28.9 million (Q4 2025), -$29.5 million (Q3 2025), and -$26.3 million (Q2 2025) per Business Quant data.